Faculty Information - RYOTARO IKEGUCHI

Published papers

Academic conference presentation

Research areas

Education

Academic & professional experience

External Researcher ID

（Last updated : 2024-07-17 08:46:48）

RYOTARO IKEGUCHI
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Internal Medicine, Division of Neurology

Position Assistant Professor

■ Published papers

1.	Case report	Clinical Experience with Dimethyl Fumarate and Natalizumab in Pregnant Women with Multiple Sclerosis: A Four-Patient Case Series 2024/07/16
2.	Case report	Clinical Experience with Dimethyl Fumarate and Natalizumab in Pregnant Women with Multiple Sclerosis: A Four-Patient Case Series 2024/07/04
3.	Case report	Chronic cerebrospinal fluid leak can cause amyotrophic lateral sclerosis mimic 2024/05/10
4.	Original article	Disease activity and progression of disability in multiple sclerosis patients aged over 50 with or without disease-modifying drug treatment: a retrospective cohort study 2023/12/05
5.	Case report	Holmes tremor in progressive multifocal leukoencephalopathy: A video case report 2023/11/27
6.	Case report	Characteristic cerebrospinal fluid findings in immune checkpoint inhibitor-related peripheral neuropathy: A case report 2022/12/05
7.	Case report	IgG4-related brain pseudotumor mimicking CNS lymphoma. A case report. 2022/12
8.	Case report	Successful treatment of progressive multifocal leukoencephalopathy that developed 21 years after renal transplantation: A case report 2022/07/03
9.	Original article	Melanoma cell adhesion molecule expressing helper T cells in CNS inflammatory demyelinating diseases 2021/07/22
10.	Original article	Paraneoplastic AQP4-IgG–Seropositive Neuromyelitis Optica Spectrum Disorder Associated With Teratoma A Case Report and Literature Review 2021/05/24
11.	Review article	Multiple sclerosis and neuromyelitis optica spectrum disorder 2021/02/01
12.	Case report	Association of IgG4-Related Arteritis With Recurrent Stroke. 2020/02
13.	Original article	Suitable indications of eculizumab for patients with refractory generalized myasthenia gravis. 2020
14.	Case report	PD-1 inhibitor-associated severe myasthenia gravis with necrotizing myopathy and myocarditis. 2019/04
15.	Original article	Proton magnetic resonance spectroscopy differentiates tumefactive demyelinating lesions from gliomas. 2018/11
16.	Case report	Chronic sarcoid myopathy manifesting only as dysphagia and dysarthria in an 84-year-old woman. 2018/10
17.	Original article	CSF and clinical data are useful in differentiating CNS inflammatory demyelinating disease from CNS lymphoma. 2018/08
18.	Review article	日常診療において、多発性硬化症への疾患修飾薬を、いつどのように変更すべきか?(When and how disease-modifying drugs for multiple sclerosis should be changed in daily practice) 2017/02
19.	Original article	Japanese cases of neuromyelitis optica spectrum disorder associated with myasthenia gravis and a review of the literature. 2014/10
20.	Original article	Rituximab used successfully in the treatment of anti-NMDA receptor encephalitis 2012/06
Display 5 items
Display all(20)

■ Academic conference presentation

1.	Satralizumab for neuromyelitis optica spectrum disorder and its contribution to polypharmacy 2022/10/20
2.	Brain pathological study in tumefactive MOG　antibody-associated disease: the role of B cells 2020/09
3.	Suitable indications of eculizumab for patients with refractory generalized myasthenia gravis 2020/08/31
4.	Differences in peripheral blood lymphocytes subsets from patients with multiples sclerosis treated with fingolimod or dumethyl fumarate 2019/09/11
5.	Differences in peripheral blood lymphocytes subsets from patients with multiples sclerosis treated with fingolimod or dimethyl fumarate 2019/09/11
6.	Programmed death 1 (PD-1) inhibitor-associated myasthenia gravis with necrotizing myopathy and myocarditis: case report and literature review 2019/06/29
7.	Melanoma cell adhesion molecule-expressing memory helper T cells in CNS-demyelinating diseases 2019/05/04
8.	Usefulness of proton magnetic resonance spectroscopy in differentiating tumefactive demyelinating lesions from gliomas 2018/04/25
9.	Pregnancy outcome and change in lymphocyte subsets in peripheral blood in Japanese patients with multiple sclerosis after assisted reproductive technology 2017/10/27
10.	Utility of CSF and clinical data in differentiating CNS inflammatory demyelinating disease from CNSlymphoma 2017/09/21
11.	Multiple sclerpsos and neuromyelitis optica spectrum disorder after assisted reproductive technology 2017/09/20
12.	Usefulness of CSF examination in diagnosis of CNS demyelinating disease and CNS lymphoma 2016/10/28
13.	Plasma osteopontin levels and expression of cytokine receptors and regulatpry T cells in peripheral blood lymphocytes during pregnancy in neuromyelitis optica spectrum disorder and multiple sclerosis 2016/09/15
14.	Usefulness of cerebrospinal fluid examination in the diagnosis of central nervous system demyelinating diseases and central nervous system-infiltrated malignant lymphoma 2016/07/09
15.	Risk of neuromyelitis optica spectrum disorder relpse associated with pregnancy on Japanese patients 2014/09/11
16.	Th1/Th2-related chemokine receptors inperipheral T cells in patients with muliple sclerosis treated with fingolimod 2014/08/01
Display 5 items
Display all(16)

■ Research areas

神経免疫, Neurology

■ Education

2018/09/21
Degree Acquisition

Tokyo Women's Medical University, Medical doctor

■ Academic & professional experience

1.	2023/09～	Lecturer
2.	2015/10～2023/08	Assistant Professor

■ External Researcher ID

orcID	0000-0002-1197-1705
Researcher ID	1000030731731